ClariVest Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-162
| Closed | – | – | 775 |
|
|
2022
Q2 | $0 | Sell |
162
-12,000
| -99% | – | ﹤0.01% | 805 |
|
|
2022
Q1 | $28K | Sell |
12,162
-53,502
| -81% | -$123K | ﹤0.01% | 454 |
|
|
2021
Q4 | $306K | Sell |
65,664
-3,197
| -5% | -$14.9K | 0.01% | 465 |
|
|
2021
Q3 | $526K | Sell |
68,861
-2,368
| -3% | -$18.1K | 0.02% | 433 |
|
|
2021
Q2 | $691K | Sell |
71,229
-58,835
| -45% | -$571K | 0.02% | 372 |
|
|
2021
Q1 | $1.08M | Buy |
130,064
+8,862
| +7% | +$73.2K | 0.04% | 276 |
|
|
2020
Q4 | $828K | Sell |
121,202
-75,553
| -38% | -$516K | 0.03% | 296 |
|
|
2020
Q3 | $2.19M | Buy |
+196,755
| New | +$2.19M | 0.07% | 209 |
|